학술논문
Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML
Document Type
Article
Author
Source
In Leukemia Research 2008 32(12):1830-1836
Subject
Language
ISSN
0145-2126